Dynavax Technologies Company Profile (NASDAQ:DVAX)

About Dynavax Technologies

Dynavax Technologies logoDynavax Technologies Corporation (Dynavax) is a clinical-stage biopharmaceutical company. The Company uses toll-like receptor (TLR) biology to discover and develop vaccines and therapeutics. Its development programs are focused on vaccines and cancer immunotherapy. The Company's lead vaccine product candidate is HEPLISAV-B, an investigational adult hepatitis B vaccine, which combines its TLR9 agonist adjuvant and recombinant hepatitis B surface antigen (rHBsAg). Its lead cancer immunotherapy candidate is SD-101, a C Class CpG TLR9 agonist is selected for characteristics optimal for treatment of cancer, including high interferon induction. Its SD-101 clinical program is intended to assess the preliminary efficacy of SD-101 in a range of tumors and in combination with a range of treatments. Its advanced inflammatory disease candidate is AZD1419. Its pipeline of product candidates for cancer immunotherapy includes DV281 and CpG-Nanoparticles, which are in the preclinical stage.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: DVAX
  • CUSIP: 26815810
Key Metrics:
  • Previous Close: $4.05
  • 50 Day Moving Average: $4.08
  • 200 Day Moving Average: $8.24
  • 52-Week Range: $38,527,000.00 - $3.20
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.08
  • P/E Growth: 0.00
  • Market Cap: $156.03M
  • Outstanding Shares: 38,527,000
  • Beta: 1.94
Profitability:
  • Net Margins: -2,650.25%
  • Return on Equity: -78.57%
  • Return on Assets: -65.94%
Debt:
  • Current Ratio: 3.86%
  • Quick Ratio: 3.86%
Additional Links:
Companies Related to Dynavax Technologies:

Analyst Ratings

Consensus Ratings for Dynavax Technologies (NASDAQ:DVAX) (?)
Ratings Breakdown: 3 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $20.17 (397.98% upside)

Analysts' Ratings History for Dynavax Technologies (NASDAQ:DVAX)
Show:
DateFirmActionRatingPrice TargetDetails
1/6/2017Cowen and CompanyReiterated RatingBuy$45.00View Rating Details
11/19/2016William BlairReiterated RatingOutperform$45.00 -> $17.00View Rating Details
11/14/2016RBC Capital MarketsSet Price TargetHold$16.00 -> $4.00View Rating Details
9/2/2016S&P Equity ResearchBoost Price Target$11.28 -> $16.01View Rating Details
4/27/2016Royal Bank of CanadaDowngradeOutperform -> Sector Perform$48.00 -> $17.00View Rating Details
4/27/2016J P Morgan Chase & CoDowngradeOverweight -> Neutral$29.00 -> $22.00View Rating Details
(Data available from 2/27/2015 forward)

Earnings

Earnings History for Dynavax Technologies (NASDAQ:DVAX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/6/2017        
11/7/2016Q3($0.75)($0.90)$2.44 million$0.20 millionViewN/AView Earnings Details
8/5/2016Q2($0.68)($0.75)$1.58 million$2.65 millionViewN/AView Earnings Details
5/9/2016Q1($0.63)($0.70)$627.00 million$942.00 millionViewN/AView Earnings Details
3/8/2016Q4($0.75)($0.70)$1.15 million$0.69 millionViewN/AView Earnings Details
11/5/2015Q3($0.78)($0.82)$1.65 million$1.20 millionViewN/AView Earnings Details
8/7/2015Q2($1.00)($0.80)$3.05 million$1.55 millionViewN/AView Earnings Details
5/7/2015($0.95)($0.97)ViewN/AView Earnings Details
3/5/2015($1.06)($0.85)ViewN/AView Earnings Details
11/5/2014Q314($0.09)($0.11)$2.50 million$2.21 millionViewN/AView Earnings Details
8/7/2014Q214($0.06)($0.09)$2.26 million$3.05 millionViewN/AView Earnings Details
5/5/2014($0.06)($0.05)ViewN/AView Earnings Details
3/10/2014Q413($0.07)($0.09)$1.56 million$2.80 millionViewN/AView Earnings Details
11/7/2013Q313($0.10)($0.09)$1.83 million$2.93 millionViewN/AView Earnings Details
7/29/2013Q2 2013($0.10)($0.09)$2.91 million$3.40 millionViewN/AView Earnings Details
5/6/2013Q113($0.11)($0.11)$2.40 million$2.10 millionViewN/AView Earnings Details
3/1/2013Q4 2012($0.11)$11.40 million$1.80 millionViewN/AView Earnings Details
11/1/2012Q312($0.08)($0.10)$5.00 million$2.90 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Dynavax Technologies (NASDAQ:DVAX)
Current Year EPS Consensus Estimate: $-3.21 EPS
Next Year EPS Consensus Estimate: $-1.95 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.52)($0.52)($0.52)
Q2 20161($0.68)($0.68)($0.68)
Q3 20161($0.74)($0.74)($0.74)
Q4 20161($0.92)($0.92)($0.92)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Dynavax Technologies (NASDAQ:DVAX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Dynavax Technologies (NASDAQ:DVAX)
Insider Ownership Percentage: 2.00%
Institutional Ownership Percentage: 84.61%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/24/2017Robert JanssenVPBuy6,000$4.04$24,240.00View SEC Filing  
6/28/2016Robert JanssenVPBuy1,452$13.68$19,863.36View SEC Filing  
5/20/2016Eddie GrayCEOBuy2,750$15.57$42,817.50View SEC Filing  
5/12/2016Robert JanssenVPBuy1,000$15.12$15,120.00View SEC Filing  
8/14/2014Eddie GrayCEOBuy25,000$1.49$37,250.00View SEC Filing  
10/30/2013Peggy V PhillipsDirectorBuy93,023$1.08$100,464.84View SEC Filing  
9/14/2012Jennifer LewVPSell18,750$4.53$84,937.50View SEC Filing  
9/13/2012Robert CoffmanVPSell8,000$4.52$36,160.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Dynavax Technologies (NASDAQ:DVAX)
DateHeadline
News IconInvesting Focus: Indicators in View on Shares of Dynavax Technologies Corp (DVAX) - Davidson Register (NASDAQ:DVAX)
davidsonregister.com - February 25 at 3:31 AM
News IconThe Technical Charts For Dynavax Technologies Corporation (DVAX) Say It All Today - NY Stock News (NASDAQ:DVAX)
nystocknews.com - February 22 at 6:55 AM
News IconInvestor Radar: Taking a Closer Look at Dynavax Technologies Corporation (NASDAQ:DVAX) - Searcy News (NASDAQ:DVAX)
searcysentinel.com - February 17 at 10:06 AM
News IconDynavax Technologies Corporation (NASDAQ:DVAX) Quarterly EPS At $-0.86 - Stock Observer (NASDAQ:DVAX)
www.thestockobserver.com - February 16 at 3:25 PM
finance.yahoo.com logoDynavax to Present at the 2017 RBC Capital Markets Global Healthcare Conference (NASDAQ:DVAX)
finance.yahoo.com - February 16 at 3:25 PM
News IconTrading Focus: Eye on Shares of Dynavax Technologies Corporation (DVAX) - Baldwin Journal (NASDAQ:DVAX)
baldwinjournal.com - February 13 at 10:36 PM
News IconTrading Focus: Eye on Shares of Dynavax Technologies Corporation (DVAX) - Rives Journal (NASDAQ:DVAX)
rivesjournal.com - February 9 at 10:25 PM
News IconDynavax Technologies Corporation (NASDAQ:DVAX) Daily Sentiment Score At 0 - Stock Observer (NASDAQ:DVAX)
www.thestockobserver.com - February 9 at 5:23 PM
News IconMarket Focus - Tracking These Shares: Dynavax Technologies Corporation (NASDAQ:DVAX) - Gilbert Daily (NASDAQ:DVAX)
gilbertdaily.com - January 30 at 11:49 AM
investornewswire.com logoStrong Sell Recommendations Of Dynavax Technologies Corporation (NASDAQ:DVAX) At 0 - Investor Newswire (NASDAQ:DVAX)
www.investornewswire.com - January 29 at 4:53 PM
News IconInvestors are Keeping Tabs on Dynavax Technologies Corporation (NASDAQ:DVAX) - The Tribune (NASDAQ:DVAX)
lakecitytribune.com - January 28 at 5:02 PM
News IconTechnical Roundup on Shares of Dynavax Technologies Corporation (DVAX) - Rives Journal (NASDAQ:DVAX)
rivesjournal.com - January 28 at 5:02 PM
News IconEarnings in Full Force, Analysts Take Aim at Dynavax Technologies Corporation (NASDAQ:DVAX) - Wall Street Beacon (NASDAQ:DVAX)
wsbeacon.com - January 27 at 11:29 PM
News IconRecent analysts Ratings: Dynavax Technologies Corporation (NASDAQ:DVAX) (NASDAQ:DVAX)
larampadinapoli.com - January 27 at 4:11 AM
News IconVice President of Dynavax Technologies Corporatio (NASDAQ:DVAX), Janssen Robert, buys 6,000 shares worth $24,240 (NASDAQ:DVAX)
empowerednews.net - January 26 at 11:08 PM
News IconWhat Are the Technicals Saying About These Shares: Dynavax Technologies Corporation (DVAX) - Sherwood Daily (NASDAQ:DVAX)
sherwooddaily.com - January 26 at 6:07 PM
News IconDynavax Technologies Corporation (NASDAQ:DVAX) Upgrades/Downgrades Update - The Newburgh Press (NASDAQ:DVAX)
newburghpress.com - January 26 at 6:07 PM
News IconStock Update: Estimates & Target in Focus for Dynavax Technologies Corporation (NASDAQ:DVAX) - Aiken Advocate (NASDAQ:DVAX)
aikenadvocate.com - January 25 at 11:06 PM
News IconEquity Rundown: RSI and CCI Check on Dynavax Technologies Corporation (DVAX) - Sherwood Daily (NASDAQ:DVAX)
sherwooddaily.com - January 24 at 5:30 PM
News IconPriming The Pump: Stock Volatility Spotted in Dynavax Technologies Corporation (NASDAQ:DVAX) - Wall Street Beacon (NASDAQ:DVAX)
wsbeacon.com - January 23 at 5:07 PM
News IconMA Levels in Review for Dynavax Technologies Corporation (DVAX) - Rives Journal (NASDAQ:DVAX)
rivesjournal.com - January 21 at 4:07 AM
News IconChart Inspection on Shares of Dynavax Technologies Corporation (DVAX) - Rives Journal (NASDAQ:DVAX)
rivesjournal.com - January 19 at 11:12 PM
seekingalpha.com logoDynavax Technologies: Valuation Of The Immune-Oncology Pipeline (NASDAQ:DVAX)
seekingalpha.com - January 19 at 6:11 PM
seekingalpha.com logoDynavax In 2017: Hero Or Zero? - Seeking Alpha (NASDAQ:DVAX)
seekingalpha.com - January 19 at 3:16 AM
News IconDynavax Technologies Corp DVAX Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:DVAX)
www.bioportfolio.com - January 18 at 5:12 PM
finance.yahoo.com logoINVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm (NASDAQ:DVAX)
finance.yahoo.com - January 17 at 10:44 PM
News IconNASDAQ:DVAX Investor News: Deadline upcoming in the Settlement of the Lawsuit against Dynavax Technologies Corporation (NASDAQ:DVAX)
www.groundreport.com - January 17 at 5:42 PM
News IconCan This Stock Gain Traction: Dynavax Technologies Corporation (NASDAQ:DVAX) - Prospect Journal (NASDAQ:DVAX)
prospectjournal.com - January 17 at 8:13 AM
News IconMarkets End Mostly Higher, How Did This Stock Fare: Dynavax Technologies Corporation (NASDAQ:DVAX) - Wall Street Beacon (NASDAQ:DVAX)
wsbeacon.com - January 15 at 4:31 AM
News IconDynavax Technologies Corporation (NASDAQ:DVAX) Bearish Target At $45 - Stock Observer (NASDAQ:DVAX)
www.thestockobserver.com - January 14 at 11:30 PM
4-traders.com logoDYNAVAX TECHNOLOGIES : Costs Associated with Exit or Disposal Activities (form 8-K/A) (NASDAQ:DVAX)
www.4-traders.com - January 13 at 5:35 PM
finance.yahoo.com logoUPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Dynavax Technologies Corporation of … (NASDAQ:DVAX)
finance.yahoo.com - January 13 at 5:35 PM
us.rd.yahoo.com logoUPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Dynavax Technologies Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 – DVAX (NASDAQ:DVAX)
us.rd.yahoo.com - January 13 at 5:35 PM
biz.yahoo.com logoDYNAVAX TECHNOLOGIES CORP Files SEC form 8-K/A, Costs Associated with Exit or Disposal Activities (NASDAQ:DVAX)
biz.yahoo.com - January 13 at 5:35 PM
investornewswire.com logoSentiments And Ratings Alert: Dynavax Technologies Corporation (NASDAQ:DVAX) - Investor Newswire (NASDAQ:DVAX)
www.investornewswire.com - January 12 at 10:35 PM
News IconWill The Needle Move For Dynavax Technologies Corporation (NASDAQ:DVAX) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:DVAX)
wsbeacon.com - January 12 at 10:35 PM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm (NASDAQ:DVAX)
finance.yahoo.com - January 12 at 10:35 PM
News IconDynavax Technologies Corporation (NASDAQ:DVAX) Quarterly EPS ... - Stock Observer (NASDAQ:DVAX)
www.thestockobserver.com - January 11 at 10:23 PM
News IconDeadline Upcoming in $4.5 Million Settlement in the Dynavax Technologies Corporation (NASDAQ:DVAX) Investor Lawsuit (NASDAQ:DVAX)
www.digitaljournal.com - January 11 at 5:23 PM
finance.yahoo.com logoDEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Dynavax Technologies Corporation (DVAX) and Lead Plaintiff Deadline: January 17, 2017 (NASDAQ:DVAX)
finance.yahoo.com - January 11 at 5:23 PM
News IconLaw Offices of Vincent Wong (NASDAQ:DVAX)
www.enhancedonlinenews.com - January 9 at 4:47 PM
News IconBearish Target Of Dynavax Technologies Corporation (NASDAQ ... - Stock Observer (NASDAQ:DVAX)
www.thestockobserver.com - January 9 at 7:55 AM
finance.yahoo.com logoDynavax to Present at J.P. Morgan 35th Annual Healthcare Conference (NASDAQ:DVAX)
finance.yahoo.com - January 9 at 7:55 AM
News IconDynavax Technologies Corporation's (DVAX) jumped 6.33% in past week (NASDAQ:DVAX)
viveremilano.biz - January 8 at 4:42 PM
marketexclusive.com logoAnalyst Activity – Cowen and Company Reiterates Buy on Dynavax Technologies Corporation (NASDAQ:DVAX) - Market Exclusive (NASDAQ:DVAX)
marketexclusive.com - January 8 at 3:48 AM
businesswire.com logoDEADLINE ALERT: Brower Piven Reminds Investors Of The January 17, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From ... (NASDAQ:DVAX)
www.businesswire.com - January 7 at 5:46 PM
News IconDEADLINE ALERT: Brower Piven Reminds ... (NASDAQ:DVAX)
ih.advfn.com - January 7 at 5:46 PM
finance.yahoo.com logoDEADLINE ALERT: Brower Piven Reminds Investors Of The January 17, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In Dynavax Technologies Corporation To Contact The Firm (NASDAQ:DVAX)
finance.yahoo.com - January 7 at 5:45 PM
nasdaq.com logoNotable Friday Option Activity: DVAX, XOM, MCD (NASDAQ:DVAX)
www.nasdaq.com - January 6 at 5:22 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm (NASDAQ:DVAX)
finance.yahoo.com - January 6 at 5:21 PM

Social

What is Dynavax Technologies' stock symbol?

Dynavax Technologies trades on the NASDAQ under the ticker symbol "DVAX."

Where is Dynavax Technologies' stock going? Where will Dynavax Technologies' stock price be in 2017?

5 brokerages have issued 1-year price objectives for Dynavax Technologies' shares. Their forecasts range from $4.00 to $45.00. On average, they expect Dynavax Technologies' share price to reach $20.17 in the next year.

When will Dynavax Technologies announce their earnings?

Dynavax Technologies is scheduled to release their next quarterly earnings announcement on Monday, March, 6th 2017.

What are analysts saying about Dynavax Technologies stock?

Here are some recent quotes from research analysts about Dynavax Technologies stock:

  • Cowen and Company analysts commented, "DVAX announced that it will undergo corporate restructuring, resulting in an ~40%." (1/6/2017)

  • According to Zacks Investment Research, "Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax's clinical development programs are based on immunostimulatory sequences which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation. " (11/28/2016)

Who owns Dynavax Technologies stock?

Dynavax Technologies' stock is owned by many different of institutional and retail investors. Top institutional investors include Federated Investors Inc. PA (9.39%), FMR LLC (3.28%), Franklin Resources Inc. (2.54%), State Street Corp (1.83%), Renaissance Technologies LLC (1.20%) and Vivo Capital LLC (0.93%). Company insiders that own Dynavax Technologies stock include Eddie Gray and Robert Janssen.

Who sold Dynavax Technologies stock? Who is selling Dynavax Technologies stock?

Dynavax Technologies' stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, FMR LLC, Allianz Asset Management AG and Royce & Associates LP.

Who bought Dynavax Technologies stock? Who is buying Dynavax Technologies stock?

Dynavax Technologies' stock was bought by a variety of institutional investors in the last quarter, including Federated Investors Inc. PA, Renaissance Technologies LLC, New Leaf Venture Partners L.L.C., Paulson & CO. Inc., Russell Investments Group Ltd. and Tudor Investment Corp Et Al. Company insiders that have bought Dynavax Technologies stock in the last two years include Eddie Gray and Robert Janssen.

How do I buy Dynavax Technologies stock?

Shares of Dynavax Technologies can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Dynavax Technologies stock cost?

One share of Dynavax Technologies stock can currently be purchased for approximately $4.05.

Dynavax Technologies (NASDAQ:DVAX) Chart for Monday, February, 27, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Dynavax Technologies (NASDAQ:DVAX)

Earnings History Chart

Earnings by Quarter for Dynavax Technologies (NASDAQ:DVAX)

Dividend History Chart

Dividend Payments by Quarter for Dynavax Technologies (NASDAQ:DVAX)

Last Updated on 2/27/2017 by MarketBeat.com Staff